Background
==========

The fourth Millennium Development Goal (MDG~4~) calls for reducing the under-five mortality rate by two-thirds between 1990 and 2015. However, only four years reaming for the deadline, only 41% decline in under-5 mortality rate has been achieved globally till 2011. As a result, about 7 million children died before their 5^th^ birthday in the year 2011 worldwide. From these, about 5 million died before the age of one and nearly 3 million died within the first 28 days of birth. This indicated that 43% of under-five deaths and 60% of infant deaths were accounted by the neonatal mortality \[[@B1]\]. This pointed out that it is difficult to achieve the desired target for the reduction of infant and under-five mortality without particular focus on neonatal mortality.

More than 98% of these deaths occurred in the low and middle income countries. Sub-Saharan Africa is, by far, the region of the world with the highest level of child as well as neonatal morbidity and mortality and remained the most troubling geographic area. In this region, 1 in 9 children dies before age five, more than 16 times the average for the developed regions (1 in 152). Similarly, this region has the highest risk of death in the first month of life and is among the regions showing the least progress \[[@B1],[@B2]\].

Most of these deaths were caused by infectious diseases, pregnancy-related complications, delivery-related complications including intra-partum asphyxia, birth trauma, and premature birth which can easily be prevented by skilled care during delivery and immediate neonatal period \[[@B1],[@B3],[@B4]\].

Skilled care during delivery has been recommended by World Health Organization (WHO) and the safe motherhood to improve the care provided to mothers during childbirth as it has a direct effect through prevention of infection, birth trauma, and asphyxia. Skilled care during labor is necessary to help normal things remain normal and to rapidly detect and deal with complications \[[@B5]-[@B8]\].

Similarly, many institutions and researchers have a doubt and have been questioning the safety of home delivery in the absence of skilled attendants. They strongly emphasize the importance of the place where a delivery takes place as complications that might arise during delivery need immediate action. They have a view that being at the right place at the time of delivery considerably increases the chances of neonatal survival \[[@B9],[@B10]\].

On the other hand, currently, there is a shift to provide skilled delivery care at the community level including at home. In the developed countries' setup such as, Australia, England and the Netherlands, it has been evidenced that safe delivery can be provided at home provided that the enabling environments are in place. As a result, many authors and institutions have been advocating that it is the right of women to choose where to give birth whether at home or at health facility \[[@B11]-[@B14]\].

However, in the middle and low-income countries' setup where there are constraints of enabling environments, the quality and safety of cares are the areas of concern. To provide quality and safe delivery care, skilled attendants need supportive contexts in which to provide care. These include a supportive legal and regulatory framework, access to essential equipment and drugs, and a functioning referral system. As evidenced by safe motherhood studies in some low and middle income countries like Benin, Rwanda, Ecuador and Jamaica, the contribution of enabling factors and essential elements to health workers' performance is critical \[[@B15]-[@B18]\]. Thus, thinking these enabling environments, the safety of home delivery is a great concern.

To come up with concrete evidence regarding the effect of health facility delivery on neonatal mortality, it is very important to have a systematic review and meta-analysis, particularly for the low and middle income countries. But, in recent years, even though there are some local studies, systematic review and meta-analysis of such studies are very scarce. The existing very few reviews were limited to the developed countries and compared only planned home births with planned hospital births. Moreover, they focused on perinatal outcomes and less attention to neonatal mortality \[[@B19],[@B20]\].

Thus, the purpose of this systematic review and met-analysis was to determine the pooled effect of health facility delivery on neonatal mortality by reviewing a pool of evidences from studies conducted all over the world.

Methods
=======

Search strategy and evaluation of studies
-----------------------------------------

Studies for this review and meta-analysis were accessed through electronic web-based search by using EndNote software. To access the records the following combination key terms were used: place of birth AND neonatal mortality, place of delivery AND neonatal mortality, health facility delivery AND neonatal mortality and home delivery AND neonatal mortality. The main databases searched were PUBMED, Cochrane Library for systematic reviews and Advanced Google Scholar. WHO databases were also searched. After identifying key relevant articles their references were also looked into (ancestor search strategy). Similarly, other studies which cited them were looked on line (descendent search strategy).

Inclusion criteria
------------------

•***Design*:** Because of ethical issues, Randomized Controlled Trial (RCT) Studies were limited on the review topic**.** As a result, all observational studies that assessed the relation between place of birth and neonatal mortality were included.

•***Publication status*:** Both published and unpublished or grey literatures including Master's and other thesis were included.

•***Language*:** Only articles published and grey literatures reported in English language were included because of inability to read and understand other languages.

•***Publication or report year*:** Though 5-10 years back is preferred for systematic review and meta-analysis, publications or reports made from January 1980-October 2012 were identified here because of the limited number of existing studies on the topic that best fit for the review.

Exclusion criteria
------------------

Articles in which the exposure and outcome variables were not clearly indicated were excluded. In addition, studies that did not use appropriate sample size determination or sampling methods and studies that compared planned hospital births (with high risk) and planned home births (low risk) or provided particular intervention for home delivery and used this intervention as a means of classification were also excluded.

Data abstraction
----------------

This review was conducted from October 15-30, 2012. The review was conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement having 27 items Checklist \[[@B21]\]. The relevance of the reviewed studies was checked based on their title, objectives, methods and key variables. Initially, by using the above stated combination key terms, studies conducted on topics related to the review title were retrieved.

Then, after excluding duplicated retrievals, studies or reports not found to be relevant for the review were excluded. For the rest, abstracts were accessed and screened based on the independent and dependent variables under review (place of birth and neonatal mortality). Studies that were found to be non-relevant were excluded during this screening. Full text articles or reports were accessed for the reaming. Based on the preset inclusion and exclusion criteria, eligibility of the studies was assessed. Two of the authors independently conducted the review and consensus was reached through discussion when there were differences. Some articles did not have adequate data in which case the corresponding authors were contacted and necessary data were obtained.

Data analysis
-------------

The necessary information was extracted from each original study by using a format prepared in Microsoft Excel spreadsheet and transferred to STATA/SE for windows version 11 for the meta-analysis. Heterogeneity among the original studies was checked by using I^2^ test statistic. As the test statistic showed significant heterogeneity among studies (I^2^ = 97%, p\<0.001) in the fixed-effects model, random-effects model was used to estimate the DerSimonian and Laird\'s pooled effect. The pooled effect was expressed in the form of relative risk.

Publication bias was checked by using funnel plot asymmetry and statistical significance test by Begg's rank correlation and Egger's linear correlation in random-effects model. As the results of the test suggested possible existence of significant publication bias (p=0.01 in Egger's test), the final effect size was determined by applying trim and fill analysis in the random-effects model.

Results
=======

Description of original studies
-------------------------------

A total of 2,330 records related to the review topic were accessed. After removing duplicated retrievals, 2,216 records remained, of which 1,942 were excluded during the initial assessment as their titles were found to be non-relevant. For the remaining 274 records, abstracts were accessed and screened. However, 237 were excluded because, the abstracts were not relevant based on the exposure and outcome variables. As a result, 37 full text articles/reports were accessed and assessed for eligibility based on the pre-set criteria. Finally, 19 studies fulfilled the eligibility criteria and included in the qualitative systematic review and quantitative meta-analysis.

Six studies, a case control study in Iran \[[@B22]\], secondary data analysis from Demographic and Health Survey (DHS) in Pakistan \[[@B23]\], RCT in Nepal \[[@B24]\], secondary data analysis in Bangladesh \[[@B25]\], case control study in Zimbabwe \[[@B26]\], and population based retrospective study in Haryana, India \[[@B27]\] were excluded because they did not have enough information for the meta-analysis, i.e., the number of total live births and number of neonatal deaths were not separately indicated and compared for facility delivery and home delivery.

Eight studies, prospective cohort studies in North America \[[@B28]\], Canada \[[@B29]-[@B31]\], England \[[@B32]\], Sweden \[[@B33]\], cross-sectional study in England and Wales \[[@B34]\] and secondary data analysis in the Netherlands \[[@B35]\] were excluded because these studies compared planned home births (assumed to have low risk) and planned facility deliveries (high risk) which were different from what this review and analysis intended to compare. This review intended to measure the difference in the occurrence of neonatal mortality regardless of certain interventions based on certain risks. In addition, these studies tried to measure perinatal mortality as primary outcome which is different from the outcome for this review, neonatal mortality.

Three studies, secondary data analysis in Democratic Republic of Congo \[[@B36]\], DHS analysis in Indonesia \[[@B37]\], and cross-sectional study in Bangladesh \[[@B38]\], were excluded because the outcome measure was perinatal mortality which is different from the outcome measure of this review (neonatal mortality). One cohort study in Bangladesh \[[@B39]\] was also excluded because of some methodological limitations. The study compared 917 home deliveries with 17 health facility deliveries. During the review, the authors hesitated for the sufficiency of the 17 health facility delivery for comparison with the 917 home deliveries and decided to exclude (Figure [1](#F1){ref-type="fig"}).
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Out of the 19 studies that were eligible and included in the systematic review and meta-analysis, almost all (18/19) were from low and middle income countries (Africa and Asia). Nine were from Africa: Nigeria \[[@B40],[@B41]\], Uganda \[[@B42]\], Malawi \[[@B43]\], Egypt \[[@B44]\], Ghana \[[@B45]\], Tanzania \[[@B46]\], Ethiopia \[[@B47]\] and Burkina Faso \[[@B48]\]. Nine were from Asia: China \[[@B49]\], India \[[@B50],[@B51]\], Iran \[[@B52]\], Vietnam \[[@B53],[@B54]\], Indonesia \[[@B55]\] and Pakistan \[[@B56],[@B57]\]. Only one was from Europe, Italy \[[@B58]\]. The publication year of these studies ranged from 1988-2012. However, the majority (14/19) of the studies were published in the last five years (2008-2012).

Regarding study design, nine were cross-sectional, five were prospective cohort study, four were case-control study, and only one was community trial. The original sample size for each study ranged from 300 in case-control study in India to 898,360 in cross-sectional study in China.

In all the 19 studies included in the review and meta-analysis, a total of 1,606,805 live births were involved. Of whom, 18,186 died within 28 days of birth, making weighted neonatal mortality rate to be 11.32 per 1000 live births. When this is stratified by the place of birth, 1,504,450 were born in health facilities among whom, 14,821 died within 28 days of birth, making weighted neonatal mortality rate among facility deliveries to be 9.85 per 1000 live births. Whereas, 102,355 were born at home among which 3,365 died within 28 days of birth, making weighted neonatal mortality rate among home deliveries to be 32.88 per 1000 live births (Table [1](#T1){ref-type="table"}).

###### 

List of 19 studies included in the meta-analysis on the effect of health facility delivery on neonatal mortality, 1988-2012

  **S/N**   **Author(s) & year of publication/report**   **Country**    **Design**            **Sample size**   **Health facility**   **Home**                   
  --------- -------------------------------------------- -------------- --------------------- ----------------- --------------------- ------------ ------------- -----------
  1         Feng *et al*., 2011                          China          Cross-sectional       898,360           840,622               6,592        57,738        1,664
  2         Parazzine *et al*., 1988                     Italy          Cross-sectional       638,438           622,381               6,488        16,057        275
  3         Owa *et al*., 1998                           Nigeria        Cross-sectional       7,225             5,741                 653          1,484         285
  4         Nathan *et al*., 2012                        Tanzania       Prospective cohort    8,593             5,146                 188          3,447         111
  5         McDermott *et al*., 1996                     Malawi         Prospective cohort    3,860             2,251                 131          1,609         133
  6         Okantey, 2008                                Ghana          Cross-sectional       536               264                   69           272           107
  7         Titaley *et al*., 2008                       Indonesia      Cross-sectional       15,800            5,948                 96           9,852         152
  8         Sharifzadeh *et al*., 2008                   Iran           Case Control          468               227                   68           241           88
  9         Nga *et al*., 2012                           Vietnam        Community trial       14,453            13,003                161          1,450         72
  10        Upadhyay *et al*., 2012                      India          Nested case control   5,444             2,871                 102          2,573         84
  11        Malqvist *et al*., 2010                      Vietnam        Case control          782               599                   80           183           58
  12        Oti *et al*., 2011                           Nigeria        Cross-sectional       5,708             2,009                 65           3,699         122
  13        Joshi, 2003                                  India          Case control          300               126                   27           174           73
  14        Tesfaye 2003                                 Ethiopia       Cross-sectional       1,462             837                   27           625           41
  15        Jehan *et al*., 2009                         Pakistan       Prospective cohort    1,121             893                   43           228           10
  16        Dialo *et al*., 2011                         Burkina Faso   Prospective cohort    864               308                   10           556           30
  17        Nankabirwa *et al*., 2011                    Uganda         Prospective cohort    835               490                   7            345           11
  18        Ayzen *et al*., 2010                         Pakistan       Cross-sectional       565               317                   11           248           4
  19        Seedhom *et al*., 2008                       Egypt          Cross-sectional       1,991             417                   3            1,574         45
                                                                        **Total**             **1,606,805**     **150,4450**          **14,821**   **102,355**   **3,365**

Pooled effect size
------------------

The pooled effect size of neonatal mortality among health facility delivery in the form of relative risk was 0.40 (95% CI: 0.39, 0.42) as compared to home delivery in the fixed effects model. However, the I^2^ test showed significant heterogeneity among studies (I^2^ = 97.0%, p \< 0.001). As a result, random effects model was used to determine the effect size. In this model, among the 19 studies included in the analysis, 10 showed statistically significant association between place of delivery and neonatal mortality and the rest 9 showed non-significant. The pooled effect size by the random-effects model became 0.64 (95% CI: 0.48, 0.85) for health facility delivery as compared to home delivery (Figure [2](#F2){ref-type="fig"}).
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Publication bias was checked by using funnel plot asymmetry as well as Begg's and Egger's test of significance. On visual observation, the funnel plot found to be asymmetric. But, the Begg's test showed no significant rank correlation with Kendall's score of −31 and p=0.28. This did not support the funnel plot asymmetry, probably because of small number of studies. As a result, Egger's test of linear correlation for absolute test was considered. This showed positive significant liner correlation with r = 2.81 (95% CI: 1.10, 4.52) and p=0.003, suggesting significant publication bias. This highlighted that studies with larger sample sizes having larger effect sizes might have been published and included in the review and meta-analysis. As a result, trim and fill analysis was done to adjust the final effect size. After trim and fill in the Random-effects model, the final pooled effect size was 0.71 (95% CI: 0.54, 0.87) with p\<0.001. This shows that there is a significant difference in the rate of neonatal mortality between neonates born at health facility and at home (Figure [3](#F3){ref-type="fig"}).
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To identify the possible causes of heterogeneity, stratified analysis was done based on the study designs, sample size and proportion of health facility delivery. In the fixed effects model, except cohort study, all the designs found to show significant effects. However, in the random effects model, cross-sectional studies and community trail studies were found to show significant effect whereas case-control studies and cohort studies did not show significant effects. The stratified analysis also revealed that there were differences in the effect size as the sample size differs. The analysis showed that the higher the sample size (\>10,000) the stronger the effect size (Table [2](#T2){ref-type="table"}).

###### 

Stratified analysis of the 19 studies included in meta-analysis based on study designs, sample size and proportion of health facility deliver, 1988-2012

  **Stratifying variable**             **Sample size**   **Fixed-effects RR (95% CI)**   **Random-effects RR (95% CI)**
  ----------------------------------- ----------------- ------------------------------- --------------------------------
  **Study design**                                                                                      
    Prospective cohort                     15,273              0.87 (0.75, 1.82)               0.82 (0.59, 1.14)
    Case-Control                            6,994              0.70 (0.60, 0.81)               0.67 (0.43, 1.03)
    Cross-Sectional                       1,570,085            0.37 (0.35, 0.38)               0.63 (0.41, 0.95)
    Community trial                        14,453              0.23 (0.19, 0.33)               0.23 (0.19, 0.33)
  **Sample size**                                                                                       
    \<1,000                                 4,350              0.62 (0.54, 0.71)               0.62 (0.47, 0.81)
    1,000-5,000                             8,434              0.63 (0.52, 0.78)               0.56 (0.36, 0.85)
    5,001-10,000                           26,970              0.76 (0.69, 0.83)               0.91 (0.62, 1.33)
    \>10,000                              1,567,051            0.32 (0.31, 0.34)               0.46 (0.25, 0.83)
  **% of health facility delivery**                                                                     
    \<50%                                  25,667              0.80 (0.71, 0.90)               0.74 (0.59, 0.94)
    ≥50%                                  1,581,138            0.37 (0.36, 0.39)               0.60 (0.43, 0.87)

Similarly, the difference in the coverage of health facility delivery resulted in variation in effect size. When proportion of health facility delivery is less than 50%, the effect size becomes 0.74 (95% CI: 0.59, 0.94), when the proportion of health facility delivery is 50% or above the effect size becomes 0.61 (95% CI: 0.43, 0.87) in the random effects model, however, in the fixed effects model this variation is much more significant (Table [2](#T2){ref-type="table"}). With this, the difference in study designs, the difference in sample sizes and the difference in the proportion of health facility delivery are likely to be the causes for the heterogeneity. It was also planned to stratify based on level of development as high income countries and middle and low income countries. However, nearly all (18/19) were from the middle and low income countries and this could not be done.

Discussions
===========

This systematic review and meta-analysis tried to assess the pooled effect of health facility delivery on neonatal mortality.

The findings revealed that health facility delivery has statistically significant effect on neonatal mortality. It has resulted in 29% reduction in risk of neonatal mortality. As nearly all of the studies included in meta-analysis were from low and middle income countries, this figure can best applies for these countries. This effect had also been observed in some prior reviews. The systematic review and Delphi estimation conducted on more than 20 studies in developing countries showed that comprehensive emergency obstetric care and basic emergency obstetric care resulted in a reduction of intra-partum related neonatal deaths by 85% and 40% respectively \[[@B59]\].

Individual country's experience also supports this finding. Portugal \[[@B60]\] and Chile \[[@B61]\] for example have shown significant reduction in neonatal mortality by expanding obstetric facilities and increasing the coverage of health facility delivery. This could be because of the fact that clean and safe delivery can be given at health facility. This in turn avoids trauma, infection and other risks that lead to morbidity and mortality of neonates.

Even though, a total of 2,216 studies were accessed, 37 original studies fit to the review topic and only 19 of them fulfilled the selection criteria. Among the 19 included studies, 14 were published in the last five years. This shows that the issue of neonatal mortality reduction through institutional delivery is a relatively recent research agenda. Because of the ethical issues, RCT studies were almost non-existent on this topic. As a result, observational studies were included. Many authors witnessed that observational studies can give valid findings with moderate effects when RCTs are not available to provide strong evidences \[[@B62]-[@B64]\]. With this, the finding of this systematic review and meta-analysis is taken as valid in showing moderate evidence.

The stratified analysis showed that the effect is higher in areas where the coverage of health facility delivery is high. When health facility delivery converge is above 50%, there is a reduction of about 40% in neonatal mortality as compared to 26% reduction when health facility delivery is less than 50%. This might be because, in areas where there is low coverage of health facility delivery, women usually give birth at home and go to the health facility after encountering some problems during labor. As a result, the child to be born is more likely to have some health problems and die during the neonatal period.

For program implication, in middle and low income countries, the issues of enabling environments need special emphasis while promoting home delivery. Because, in areas where there is shortage of equipments, drugs and other supplies together with problem of emergency referral, the safety of home delivery in reducing neonatal mortality may be under question. Thus, in such areas encouraging women to give birth in health facilities where necessary enabling environments are in place is very essential. Moreover, health facility delivery will also create an opportunity for the mother and the newborn to receive immunization and other necessary health information on preventive measures that may have an effect on preventing neonatal death.

Because of the variation in the design, sample size and the proportion of health facility delivery, significant heterogeneity among the studies was observed. As a result, random effects model was used to estimate the final pooled effect. Similarly, because of the existence of significant publication bias, trim and fill analysis was used. These might have underestimated the true effect of health facility delivery on neonatal mortality. So, it is important to note of this while interpreting and using this findings.

This systematic review and meta-analysis may have limitations as it was limited to publications and reports made in English language and observational studies. In addition, because of the nature of the meta-analysis that uses aggregated group data, the skill of the delivery attendant and other confounding factors were not controlled. This might have affected the effect size. Therefore, the findings of this systematic review and meta-analysis should be interpreted in the context of both inherent limitations of the original studies and the current reviews and analysis.

Conclusions and recommendations
===============================

This meta-analysis found statistically significant association between place of delivery and neonatal mortality. In the low and middle income countries, health facility delivery was found to reduce the risk of neonatal mortality by 29%. Therefore, expansion of health facilities and promotion of their utilization are essential in areas where home delivery is a common practice and enabling environments are scarce. In addition, longitudinal studies need to be encouraged in areas where studies are lacking to come up with a more precise effect.
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